These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26118578)

  • 1. Ecstasy induced acute hepatic failure. Case reports.
    Atayan Y; Çağın YF; Erdoğan MA; Harputluoglu MM; Bilgic Y
    Acta Gastroenterol Belg; 2015; 78(1):53-5. PubMed ID: 26118578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute liver failure following the use of ecstasy (MDMA)].
    Lange-Brock N; Berg T; Müller AR; Fliege H; Neuhaus P; Wiedenmann B; Klapp BF; Mönnikes H
    Z Gastroenterol; 2002 Aug; 40(8):581-6. PubMed ID: 12297982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3,4-methylenedioxymethamphetamine (MDMA): an important cause of acute hepatitis.
    Brncić N; Kraus I; Visković I; Mijandrusić-Sincić B; Vlahović-Palcevski V
    Med Sci Monit; 2006 Nov; 12(11):CS107-9. PubMed ID: 17072276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Variability of the clinical expression of Ecstasy-induced hepatotoxicity].
    Núñez O; Bañares R; Barrio J; Menchén L; Diego Ad; Salinero E; Clemente G
    Gastroenterol Hepatol; 2002 Oct; 25(8):497-500. PubMed ID: 12361531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute hepatitis due to ingestion of Ecstasy].
    Huarte Muniesa MP; Pueyo Royo AM
    Rev Esp Enferm Dig; 1995 Sep; 87(9):681-3. PubMed ID: 7577130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option.
    Garbino J; Henry JA; Mentha G; Romand JA
    Vet Hum Toxicol; 2001 Apr; 43(2):99-102. PubMed ID: 11308131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute liver failure caused by methylenedioxymethamphetamine ('ecstasy')].
    de Man RA; Wilson JH; Tjen HS
    Ned Tijdschr Geneeskd; 1993 Apr; 137(14):727-9. PubMed ID: 8097286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecstasy induced fatal hepatic failure.
    Colak Y; Tuncer I; Enc FY; Ozturk O; Kiziltas S; Ulasoglu C
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):215-6. PubMed ID: 21725523
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic exposure to ethanol exacerbates MDMA-induced hyperthermia and exposes liver to severe MDMA-induced toxicity in CD1 mice.
    Pontes H; Duarte JA; de Pinho PG; Soares ME; Fernandes E; Dinis-Oliveira RJ; Sousa C; Silva R; Carmo H; Casal S; Remião F; Carvalho F; Bastos ML
    Toxicology; 2008 Oct; 252(1-3):64-71. PubMed ID: 18761051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: multidetector CT and pathology findings.
    Lawler LP; Abraham S; Fishman EK
    J Comput Assist Tomogr; 2001; 25(4):649-52. PubMed ID: 11473199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Ecstasy"-induced hepatitis in an active duty soldier.
    Hwang I; Daniels AM; Holtzmuller KC
    Mil Med; 2002 Feb; 167(2):155-6. PubMed ID: 11873540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ecstasy-induced toxic hepatitis].
    Aknine X
    Presse Med; 2004 Oct; 33(18 Suppl):18-20. PubMed ID: 15617171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Auxiliary liver transplantation for acute liver failure after intake of 3,4-methylenedioxymethamphetamine ("Ecstasy")].
    Hellinger A; Rauen U; de Groot H; Erhard J
    Dtsch Med Wochenschr; 1997 May; 122(22):716-20. PubMed ID: 9213536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute hepatitis due to ecstasy].
    Roques V; Perney P; Beaufort P; Hanslik B; Ramos J; Durand L; Le Bricquir Y; Blanc F
    Presse Med; 1998 Mar; 27(10):468-70. PubMed ID: 9767974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ecstasy: a common cause of severe acute hepatotoxicity.
    Andreu V; Mas A; Bruguera M; Salmerón JM; Moreno V; Nogué S; Rodés J
    J Hepatol; 1998 Sep; 29(3):394-7. PubMed ID: 9764985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis from ecstasy].
    Giner Durán R; Flors H; Millán M; Manzanera R
    Gastroenterol Hepatol; 1998 Mar; 21(3):158. PubMed ID: 9607299
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute hepatitis induced by Ecstasy].
    Indart Pérez A; Mendia Gorostidi A; Barrio Andrés J; Arens Miravé I
    Gastroenterol Hepatol; 1998 Dec; 21(10):499. PubMed ID: 9927798
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature.
    Carvalho M; Carvalho F; Remião F; de Lourdes Pereira M; Pires-das-Neves R; de Lourdes Bastos M
    Arch Toxicol; 2002 Apr; 76(3):166-72. PubMed ID: 11967622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMA-Associated Liver Toxicity: Pathophysiology, Management, and Current State of Knowledge.
    Cajanding RJM
    AACN Adv Crit Care; 2019; 30(3):232-248. PubMed ID: 31462520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasy.
    Brauer RB; Heidecke CD; Nathrath W; Beckurts KT; Vorwald P; Zilker TR; Schweigart U; Hölscher AH; Siewert JR
    Transpl Int; 1997; 10(3):229-33. PubMed ID: 9163865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.